For the third quarter of FY June 2026, net sales were 52,449 million yen (YoY +7.9%), and operating income was 2,304 million yen (YoY +2.7%), nearly in line with the plan.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"9267","jir_company_name":"Genky DrugStores Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2605","jir_publication_date":"2026-04-28","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/04\/9267-20260428-03.pdf","jir_short_summary":"For the third quarter of FY June 2026, net sales were 52,449 million yen (YoY +7.9%), and operating income was 2,304 million yen (YoY +2.7%), nearly in line with the plan.","jir_summary":"### Overview of Performance\nFor the third quarter of FY June 2026, net sales amounted to 52,449 million yen (YoY +7.9%) and operating income was 2,304 million yen (YoY +2.7%). Sales fell short of the plan by approximately 0.8%, but operating income reached the planned level. Same-store sales improved toward the latter half of Q3, with customer traffic steadily increasing by +1.5% YoY. Gross profit margin was almost on plan with a slight 0.1 point decrease compared to the plan. Selling, general and administrative expenses increased due to higher personnel and utility costs, but were contained by stable operation of self-checkout registers and a work transfer system.\n\n### Outlook and Plans\nFull-year earnings forecast projects net sales of 221,200 million yen (YoY +10.2%) and operating income of 11,050 million yen (YoY +14.4%). Three new large-scale stores are planned to open during the fiscal year, with eight closures. The company aims to enhance profitability by balancing gross profit margin and SG&A expenses while maintaining price competitiveness. EPS is forecast at 257.5 yen, with a target ROE of 14.5%.","jir_financial_highlights":"Net Sales: 52,449 million yen (YoY +7.9%)\nOperating Income: 2,304 million yen (YoY +2.7%)\nQuarterly Net Income: 1,601 million yen (YoY -0.2%)\nFull-year Net Sales Forecast: 221,200 million yen (YoY +10.2%)\nFull-year Operating Income Forecast: 11,050 million yen (YoY +14.4%)\nEPS: 257.5 yen (YoY unknown)\nNumber of New Store Openings (Cumulative): 31 stores (As planned)","jir_category":"","jir_hashtags":"#GenkyDrugStores, #EarningsPresentation, #JapaneseStocks","jir_key_figures":"Net Sales (Q3 Results): 52,449 million yen (YoY +7.9%)\nOperating Income (Q3 Results): 2,304 million yen (YoY +2.7%)\nFull-year Net Sales Forecast: 221,200 million yen (YoY +10.2%)","jir_meta_title":"\u3010Genky DrugStores\u3011FY2026 Q3 Earnings | Net Sales 52.4 Billion Yen (YoY +7.9%)","jir_meta_description":"Genky DrugStores Co., Ltd. Q3 FY June 2026 earnings. Net sales came to 52,449 million yen (YoY +7.9%) and operating income was 2,304 million yen (YoY +2.7%), nearly in line with plan.","jir_og_title":"\u3010Genky DrugStores\u3011FY2026 Q3 Earnings | Net Sales 52.4 Billion Yen (+7.9%)","jir_og_description":"Q3 FY June 2026 results reporting net sales of 52,449 million yen and operating income of 2,304 million yen, nearly aligned with plan.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Net Sales Trend (FY2024 to FY2026 Q3)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2024 1Q\\\",\\\"FY2024 2Q\\\",\\\"FY2024 3Q\\\",\\\"FY2025 1Q\\\",\\\"FY2025 2Q\\\",\\\"FY2025 3Q\\\",\\\"FY2026 1Q\\\",\\\"FY2026 2Q\\\",\\\"FY2026 3Q\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales (million yen)\\\",\\\"data\\\":[46871,45095,44619,50050,48708,48624,56042,53218,52449],\\\"borderColor\\\":\\\"#3e95cd\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":true}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend (FY2024 to FY2026 Q3)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2024 1Q\\\",\\\"FY2024 2Q\\\",\\\"FY2024 3Q\\\",\\\"FY2025 1Q\\\",\\\"FY2025 2Q\\\",\\\"FY2025 3Q\\\",\\\"FY2026 1Q\\\",\\\"FY2026 2Q\\\",\\\"FY2026 3Q\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income (million yen)\\\",\\\"data\\\":[2015,2371,2107,2272,2323,2243,2916,2801,2304],\\\"borderColor\\\":\\\"#8e5ea2\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":true}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"gross_margin_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Gross Profit Margin Trend (FY2024 to FY2026 Q3)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2024 1Q\\\",\\\"FY2024 2Q\\\",\\\"FY2024 3Q\\\",\\\"FY2025 1Q\\\",\\\"FY2025 2Q\\\",\\\"FY2025 3Q\\\",\\\"FY2026 1Q\\\",\\\"FY2026 2Q\\\",\\\"FY2026 3Q\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Gross Profit Margin (%)\\\",\\\"data\\\":[19.9,20.9,19.8,20.2,20.1,20.3,20.8,20.4,20.1],\\\"borderColor\\\":\\\"#3cba9f\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":true}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"sg_and_a_ratio_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"SG&A Expense Ratio Trend (FY2024 to FY2026 Q3)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2024 1Q\\\",\\\"FY2024 2Q\\\",\\\"FY2024 3Q\\\",\\\"FY2025 1Q\\\",\\\"FY2025 2Q\\\",\\\"FY2025 3Q\\\",\\\"FY2026 1Q\\\",\\\"FY2026 2Q\\\",\\\"FY2026 3Q\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"SG&A Ratio (%)\\\",\\\"data\\\":[15.6,15.7,15.1,15.6,15.4,15.7,15.0,15.3,15.7],\\\"borderColor\\\":\\\"#e8c3b9\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":true}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"operating_margin_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Margin Trend (FY2024 to FY2026 Q3)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"FY2024 1Q\\\",\\\"FY2024 2Q\\\",\\\"FY2024 3Q\\\",\\\"FY2025 1Q\\\",\\\"FY2025 2Q\\\",\\\"FY2025 3Q\\\",\\\"FY2026 1Q\\\",\\\"FY2026 2Q\\\",\\\"FY2026 3Q\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Margin (%)\\\",\\\"data\\\":[4.3,5.3,4.7,4.5,4.8,4.6,5.2,5.3,4.4],\\\"borderColor\\\":\\\"#c45850\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":true}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}]","ir_related_company":9174,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-43758","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n